Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Jenny Xie, PhD
Head of In Vivo Discovery at Editas Medicine
Speaker

Profile

Jenny Xie joined Editas Medicine in 2024 as Senior Director of Discovery Therapeutics. She brings deep expertise in in vivo drug development, with over 10 years of experience across multiple gene editing platforms and disease indications. In her current role, Jenny oversees Editas’ preclinical in vivo gene editing therapeutics discovery and technology development activities.

Agenda Sessions

  • Transformative LDL Cholesterol Lowering In Vivo CRISPR Gene Editing Approach for Hyperlipidemia and Atherosclerotic Cardiovascular Disease

    , 8:30am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Jenny at TIDES USA: Oligonucleotide & Peptide Therapeutics